Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5536339 | Vaccine | 2017 | 7 Pages |
Abstract
The RV vaccination programme clearly controlled the severe, hospital-treated forms of RVGE. The total disease burden is a more valuable end point than mere specifically diagnosed cases as laboratory confirmation practises usually change after vaccine introduction. The RV vaccination programme annually pays for itself at least two times over.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Tuija Leino, Ulrike Baum, Peter Scott, Jukka Ollgren, Heini Salo,